Evidence map›Paper›PMID 31887630›Full record

ArticleTranslational oncology2020

Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.

Macus Tien Kuo, Yan Long, Wen-Bin Tsai, Ying-Ying Li, Helen H W Chen, Lynn G Feun, Niramol Savaraj

Open access · goldAbstract read
In one paragraph

Article in Translational oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Beyond the Limit: MYC Mediates Tumor Immune Escape.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. EphA2 signaling within integrin adhesions regulates fibrillar adhesion elongation and fibronectin deposition.Matrix biology : journal of the International Society for Matrix Biology · 2021
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Eph/Ephrin-Based Protein Complexes: The Importance ofFrontiers in molecular biosciences · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Macus Tien KuoDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: tienkuo@sbcglobal.net.
Yan LongDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wen-Bin TsaiDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ying-Ying LiDepartment of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Helen H W ChenDepartment of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70428, Taiwan.
Lynn G FeunSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Niramol SavarajDepartment of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA; Division of Hematology and Oncology, Miami Veterans Affairs Healthcare System, Miami, FL, USA. Electronic address: nsavaraj@med.miami.edu.
The University of Texas MD Anderson Cancer Center · USMiami VA Healthcare System · USNational Cheng Kung University Hospital · TWSylvester Comprehensive Cancer Center · USUniversity of Miami · US

Funding

Improving the Efficacy of Cisplatin-Based Cancer ChemotherapyR01CA149260 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUO, MACUS T · 2010 to 2014
$1.6M
Overcoming BRAF and MEK Inhibitors Resistance in Advanced MelanomaI01BX003328 · VA · MIAMI VA HEALTH CARE SYSTEM · PI SAVARAJ, NIRAMOL · 2016 to 2019
–
BLRD VA I01 BX003328NCI NIH HHS R01 CA149260
6 · The paper itself

Abstract

Many human malignancies require extracellular arginine (Arg) for survival because the key enzyme for de novo Arg biosynthesis, argininosuccinate synthetase 1 (ASS1), is silenced. Recombinant arginine deiminase (ADI-PEG20), which digests extracellular Arg, has been in clinical trials for treating ASS1-negative tumors. Reactivation of ASS1 is responsible for the treatment failure. We previously demonstrated that ASS1 reactivation is transcriptionally regulated by c-Myc via the upstream Gas6-Axl tyrosine kinase (RTK) signal. Here, we report that another RTK EphA2 is coactivated via PI3K-ERK/RSK1 pathway in a ligand-independent mechanism. EphA2 is also regulated by c-Myc. Moreover, we found that knockdown Axl upregulates EphA2 expression, demonstrating cross-talk between these RTKs. ADI

Identifiers

PMID31887630
PMCPMC6938815
OpenAlexW2998287802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.